Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,56.05,11/12/2014,GNRL,158557312
22868,GNRL,"Boston Scientific Corporation",MA,100000005674,25.40,11/19/2013,GNRL,101916322
22868,GNRL,"Boston Scientific Corporation",MA,100000005674,23.90,09/10/2015,GNRL,245920004
22868,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,22.39,07/18/2014,GNRL,149669798
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,18.56,11/06/2015,GNRL,270015234
22868,GNRL,"AbbVie, Inc.",IL,100000000204,18.08,03/27/2015,GNRL,309388202
22868,GNRL,"AbbVie, Inc.",IL,100000000204,18.01,07/28/2014,GNRL,189426326
22868,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.97,10/02/2015,GNRL,260107298
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,17.20,01/14/2015,GNRL,270015272
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,17.12,05/14/2015,GNRL,339620640
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,16.43,10/27/2014,GNRL,158548290
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.40,10/05/2015,GNRL,339592362
22868,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.05,06/05/2015,GNRL,337161504
22868,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,16.02,06/09/2014,GNRL,149665726
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.55,12/22/2014,GNRL,158764678
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.55,01/08/2015,GNRL,295288202
22868,GNRL,"Braintree Laboratories, Inc.",MA,100000000153,15.40,02/15/2015,GNRL,252767320
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,15.25,08/08/2014,GNRL,158796654
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.99,06/10/2014,GNRL,156101620
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,14.84,11/17/2014,GNRL,158866236
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.72,02/27/2015,GNRL,339481464
22868,GNRL,"AbbVie, Inc.",IL,100000000204,14.50,04/17/2015,GNRL,317249042
22868,GNRL,"AbbVie, Inc.",IL,100000000204,14.48,06/19/2015,GNRL,317075024
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,14.35,05/13/2015,GNRL,270015245
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,14.20,05/30/2014,GNRL,187551180
22868,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.99,10/23/2015,GNRL,337377262
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.35,10/03/2014,GNRL,158893708
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.25,07/14/2014,GNRL,158565102
22868,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.25,02/04/2015,GNRL,260075454
22868,GNRL,"Boston Scientific Corporation",MA,100000005674,13.02,01/02/2014,GNRL,152893092
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,13.00,11/07/2014,GNRL,158728450
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.87,09/11/2014,GNRL,156101624
22868,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.80,04/14/2015,GNRL,260113764
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,12.77,01/13/2015,GNRL,295288206
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,12.67,05/23/2014,GNRL,158647546
22868,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.65,12/22/2014,GNRL,148354394
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,12.62,12/01/2014,GNRL,158582748
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.38,07/17/2015,GNRL,339343996
22868,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.15,10/31/2014,GNRL,193915698
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,12.15,02/18/2015,GNRL,270015270
22868,GNRL,"AbbVie, Inc.",IL,100000000204,12.04,09/14/2015,GNRL,317150700
22868,GNRL,"AbbVie, Inc.",IL,100000000204,11.60,05/29/2015,GNRL,317386874
22868,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,11.45,11/18/2013,GNRL,21676278
22868,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,11.38,06/20/2014,GNRL,192309364
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.38,06/01/2015,GNRL,339247816
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,11.31,07/29/2014,GNRL,156101622
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,11.20,02/06/2015,GNRL,270015264
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.79,08/22/2015,GNRL,339199124
22868,GNRL,"AbbVie, Inc.",IL,100000000204,10.78,03/07/2014,GNRL,189203750
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,10.78,03/11/2015,GNRL,270015240
22868,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.75,02/13/2014,GNRL,148275046
22868,GNRL,"AbbVie, Inc.",IL,100000000204,10.68,02/20/2015,GNRL,309087638
22868,GNRL,"Ferring Pharmaceuticals Inc.",NJ,100000000309,10.60,04/11/2014,GNRL,192309346
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.37,01/26/2015,GNRL,339161344
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,10.16,09/12/2014,GNRL,158868520
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.54,03/06/2015,GNRL,339129616
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,9.45,08/07/2015,GNRL,270015254
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,9.45,03/03/2015,GNRL,339126894
22868,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.33,01/23/2015,GNRL,336855504
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,8.03,06/01/2015,GNRL,270015260
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,6.88,01/21/2015,GNRL,339048804
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.63,01/06/2015,GNRL,338992486
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.45,08/12/2015,GNRL,338987838
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,4.45,08/12/2015,GNRL,338987840
22868,GNRL,"Actavis Pharma Inc",NJ,100000010642,3.88,02/18/2015,GNRL,338973458
22868,GNRL,"Janssen Biotech, Inc.",PA,100000000329,2.95,05/13/2015,GNRL,270015250
22868,GNRL,"Salix Pharmaceuticals, Ltd",NC,100000010796,0.89,09/12/2014,GNRL,158782748
